To Get Help Now
Click Here
 
Today's Date:

Panel to Consider Zoloft Consolidation

AddThis Social Bookmark Button

Approximately 95 federally filed Zoloft birth defect lawsuits are being considered for consolidation by the U.S. Judicial Panel for Multidistrict Litigation. The lawsuits were filed in sixteen federal district courts across the country against Pfizer, alleging the company failed to warn physicians and consumers about the increased risks of birth defects when Zoloft is taken by pregnant women.

According to the complaints, taking Zoloft during pregnancy can cause serious and potentially life threatening injuries to babies, including heart, lung, abdominal, and cranial defects and malformations, spina bifida, and persistent pulmonary hypertension in newborns (PPHN), as well as other defects and injuries.

Court filings by Pfizer indicate that the number of product liability lawsuits filed against Pfizer over Zoloft birth defects has risen 60 percent since the company filed the consolidation motion on January 18.

Pfizer requested the cases be transferred to the U.S. District Court for the Southern District of New York, while some plaintiffs argue the cases should be transferred to the Eastern District of Pennsylvania, or the Southern District of Illinois.

The hearing before the MDL Panel is set for today and a decision on consolidation should be given within a few weeks. The panel will also decide upon the venue for the consolidation.

 

breakinglawsuitnews.com disclaimer: This article: Panel to Consider Zoloft Consolidation was posted on Thursday, March 29th, 2012 at 7:56 pm at breakinglawsuitnews.com and is filed under Uncategorized.

« »

Comments are closed.